Table 3 Comparison of AKI in patients with HIV to patients without HIV or in whom HIV status was unknown
No HIV or HIV unknown (n = 63) | HIV (n = 90) | P value | |
|---|---|---|---|
Demographics | |||
Age (median; IQR) | 53 (35–71) | 38 (32–46) | 0 · 0004 |
Male sex | 35 (55 · 6%) | 57 (63 · 3%) | 0 · 334 |
Primary cause of AKI | |||
Sepsis and hypoperfusion | 51 (80 · 1%) | 82 (91 · 1%) | 0 · 058a |
Toxin | 1 (1 · 6%) | 4 (4 · 4%) | |
Obstruction | 6 (9 · 5%) | 1 (1 · 1%) | |
Parenchymal Kidney disease | 2 (3 · 2%) | 2 (2 · 2%) | |
Unclear | 3 (4 · 8%) | 1 (1 · 1%) | |
AKI Severity | |||
AKI Stage 3 | 39 (61 · 9%) | 54 (60 · 0%) | 0 · 81 |
Outcomes | |||
In-hospital mortality | 22 (37 · 9%) | 42 (48 · 4%) | 0 · 20 |
Length of stay in days (median; IQR) | 7 · 5 (4–13) | 7 · 5 (5–11) | 0 · 74 |
Renal recovery (any) | 27 (49 · 1%) | 41 (49 · 4%) | 0 · 97 |
Persistent kidney injury at dischargeb | 19 (70 · 4%) | 24 (58 · 4%) | 0 · 32 |